Genocea Biosciences To Present At The 14th Annual Needham & Co. Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Jonathan Poole, chief financial officer, will present a company overview at the upcoming 14th Annual Needham & Co. Healthcare Conference. The presentation is scheduled for Wednesday, April 15, 2015 at 9:20 a.m. EDT in New York, NY.

Help employers find you! Check out all the jobs and post your resume.